Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:1356-1366
Published online before print September 10, 2007, doi: 10.1161/CIRCULATIONAHA.107.728857
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/12/1356    most recent
CIRCULATIONAHA.107.728857v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, M.-Q.
Right arrow Articles by He, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, M.-Q.
Right arrow Articles by He, L.
Related Collections
Right arrow Clinical genetics
Right arrow ACE/Angiotension receptors
Right arrow Risk Factors
Right arrow Quantitative modeling
Right arrow Acute coronary syndromes
Right arrow Epidemiology
Right arrow Genetics of cardiovascular disease

(Circulation. 2007;116:1356-1366.)
© 2007 American Heart Association, Inc.


Coronary Heart Disease

Quantitative Assessment of the Effect of Angiotensinogen Gene Polymorphisms on the Risk of Coronary Heart Disease

Ming-Qing Xu, PhD*; Zheng Ye, PhD*; Frank B. Hu, MD, PhD; Lin He, PhD

From the Bio-X Life Science Research Centre, Shanghai Jiao Tong University, Shanghai, China (M.-Q.X., L.H.); Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China (M.-Q.X., L.H.); School of Public Health, Harvard University, Boston, Mass (M.-Q.X., F.B.H.); Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass (F.B.H.); and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK (Z.Y.).

Correspondence to Professor Lin He, PhD, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 294 Yuan Rd, Shanghai 200031, China (e-mail helin{at}bio-x.cn); or Dr Ming-Qing Xu, School of Public Health, Harvard University, 651 Huntington Ave, Boston, MA 02115 (e-mail mxu@hsph.harvard.edu).

Received April 9, 2007; accepted July 23, 2007.

Background— Angiotensinogen, a key protein in the renin-angiotensin system, plays an important role in cardiovascular hemostasis. Many studies have examined the association between polymorphisms in the angiotensinogen gene and risk of coronary heart disease (CHD), but the results have been inconsistent.

Methods and Results— We performed a meta-analysis of 43 associations studies on 2 angiotensinogen polymorphisms (M235T and T174M) and risk of CHD published before March 2007, including a total of 13 478 CHD cases and 17 024 controls. We also explored potential sources of heterogeneity. In a combined analysis, the summary per-allele odds ratio for CHD of the M235T polymorphism was 1.11 (95% confidence interval, 1.03 to 1.19). However, when the analyses were restricted to 4 larger studies (n >500 cases), the summary per-allele odds ratio was 0.99 (95% confidence interval, 0.94 to 1.04). Our analyses detected a possibility of publication bias with an overestimate of the true association by smaller studies. A meta-analysis of studies on the 174M variant showed no significant overall association with CHD, yielding a per-allele odds ratio of 1.07 (95% confidence interval, 0.93 to 1.22).

Conclusions— This meta-analysis suggested an overall weak association between the M235T polymorphism and CHD risk. However, the association was not observed in several larger studies, suggesting a publication bias. Additional very large-scale studies are warranted to provide conclusive evidence on the effects of the angiotensinogen gene and other genes within the renin-angiotensin system on risk of CHD.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
ESC Textbook of Cardiovascular MedicineHome page
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth
CHAPTER 9 Genetics of Cardiovascular Diseases
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. B. van der Net, J. van Etten, M. Yazdanpanah, G. M. Dallinga-Thie, J. J.P. Kastelein, J. C. Defesche, R. P. Koopmans, E. W. Steyerberg, and E. J.G. Sijbrands
Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia
Eur. Heart J., June 1, 2008; 29(11): 1370 - 1376.
[Abstract] [Full Text] [PDF]